Perfluoro-n-[1,2-13C2] hexanoic acid

If you drink from a private well, live near an industrial site, or work around firefighting foam, you have a concrete reason to know how much short-chain PFAS is moving through your body right now. This test looks for a fast-clearing forever chemical in urine that reflects recent contact rather than a lifetime of buildup.

That timing is the whole point. Because your body flushes this particular chemical out within weeks, a urine result is a snapshot of what you have been exposed to lately, which makes it useful for catching an ongoing source you can actually change.

What This Test Actually Measures

The full name on the test, Perfluoro-n-[1,2-13C2] hexanoic acid, describes a version of the chemical tagged with heavier carbon atoms. In the lab, that tagged version is a measuring tool (an internal reference standard) that helps quantify the real target: perfluorohexanoic acid, or PFHxA, in your urine.

PFHxA is a short-chain, six-carbon industrial chemical, not something your body produces. It gets into people from the outside, mainly through contaminated drinking water, dust, food, and consumer products treated to resist water and grease. So a result here is best read as an exposure signal, not as a hormone, enzyme, or disease number your body generates on its own.

This is an exploratory marker. There are no standardized clinical cutoffs that tell you a single number is safe or dangerous, and a single reading should not drive decisions on its own. What it can give you is an early, practical window into recent exposure, which is exactly why a baseline now is worth having as the science matures.

A Snapshot, Not a Lifetime Record

PFHxA clears the body quickly compared to the better-known PFAS. Human estimates put its geometric mean half-life at roughly 32 days, with a reported range of about 14 to 49 days in studies of ski wax technicians and other exposed workers. In plain terms, most of a given exposure is gone within a couple of months.

That is very different from the older long-chain forever chemicals like PFOA and PFOS, which linger in blood for years. Those are tracked in serum because they accumulate over a lifetime. A urine PFHxA result instead reflects recent or ongoing contact, which is what makes it good at flagging a live exposure source.

How often it shows up depends heavily on who is being tested. In a large U.S. survey, urinary PFHxA was detected in only about 1 in 5 people (22.6%), and roughly two-thirds of participants had no detectable urinary PFAS at all (67.5%). By contrast, it was found in 100% of Austrian schoolchildren and 100% of children studied in Shanghai, pointing to widespread low-level contact in some groups even when general-population detection is spotty.

The Kidney Connection

The kidney is the organ that matters most for this chemical. Short-chain PFAS like PFHxA are cleared largely through the kidneys into urine, which is why urine can reflect the burden passing through them. When kidney handling of these compounds is central, the organ doing the work is also the one worth watching.

Human evidence tying PFAS exposure to kidney measures is still indirect and mostly comes from mixtures of PFAS rather than PFHxA alone. In population studies, higher PFAS exposure has been associated with higher uric acid and creatinine and lower estimated filtration rate, all signs of reduced kidney performance. In animal studies, high-dose PFHxA damaged kidney tissue, though this has not been confirmed as a human effect at real-world exposure levels.

Mixed Signals in the Liver

Liver findings for PFHxA specifically point in different directions. In one Canadian study where PFHxA was found in every participant, higher levels were associated with a higher liver enzyme called GGT (gamma-glutamyl transferase, which can rise with liver stress). In a small North Carolina community, however, higher PFHxA in blood was linked to lower levels of two other liver enzymes, AST and ALT.

This apparent contradiction is easier to understand once you stop treating PFHxA as a clean good-number, bad-number marker. It is an exposure indicator, measured in small cross-sectional studies where people are exposed to many PFAS at once, so a single enzyme moving up or down does not establish that PFHxA itself is driving liver injury. The broader and stronger liver evidence in humans comes from the older long-chain PFAS, not from PFHxA.

What the Wider PFAS Research Suggests

Across the PFAS family, exposure has been linked to thyroid disruption, lower birth weight, changes in cholesterol, and immune effects. Almost all of that evidence is driven by other PFAS, not by urinary PFHxA, so it provides context rather than a direct verdict on this specific marker.

The closest direct clinical signal is limited. A case-control study of childhood congenital heart disease found that higher PFHxA measured in blood was associated with more than twice the odds of the condition (odds ratio 2.62, 95% CI 1.99 to 3.45). That finding used plasma rather than urine, was not a forward-looking study, and cannot separate PFHxA from the other chemicals people were exposed to, so it should be read as a hypothesis, not a proven risk for a urine result.

Why One Reading Is Not Enough

For a fast-clearing chemical measured in spot urine, a single value can bounce around a lot. Studies of other urinary markers in healthy people have found that within-person swings can range widely, sometimes far more than 100% from one sample to the next, depending on time of day, hydration, and recent diet. A one-off number is a starting point, not a conclusion.

Tracking the trend is where this test earns its keep. Get a baseline, then retest after you change a suspected source, such as switching to filtered or bottled water, and see whether the number falls. Because PFHxA clears in weeks, a follow-up test 1 to 3 months after removing a source can actually show whether your effort worked, and at least annual testing makes sense if you have ongoing exposure risk.

When a Single Reading Can Fool You

• Urine dilution: how much water you have had shifts the concentration up or down without changing your true exposure. Labs often adjust to urinary creatinine to correct for this, which makes results more comparable over time.
• Timing of the sample: spot urine varies through the day, so collection time can move the number. Trying to collect at a consistent time helps when you are comparing readings.
• Wrong matrix for the question: urine reflects recent short-chain exposure and largely misses the long-lived PFAS that accumulate in blood. A clean urine result does not mean your long-chain PFAS burden is low.
• Assay scope: any single PFAS test covers only part of a very large chemical family, so a low PFHxA does not rule out other PFAS you were not tested for.

What to Do With an Unexpected Result

A higher-than-expected result is a prompt to investigate the source, not to panic. The most useful next step is to look at your drinking water, especially if you use a private well or live near an industrial or firefighting site, and to consider testing the water itself. Because this chemical clears quickly, cutting a source often shows up as a falling number on a repeat test.

On the health side, pairing this test with kidney markers (creatinine, cystatin C, uric acid, and an estimated filtration rate) and liver enzymes gives context for the organs most discussed with PFAS. If you want the full exposure picture, a blood-based PFAS panel captures the long-lived compounds that urine misses. For a persistently high result or a known occupational or water contamination, an environmental or occupational medicine specialist is the right person to interpret it alongside your exposure history.